International Biotechnology Trust plc
IBT.L · LSE
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Revenue | £18,686 | £42,338 | £8,494 | £22,143 |
| % Growth | -55.9% | 398.4% | -61.6% | – |
| Cost of Goods Sold | £4,303 | £2,198 | £2,324 | £2,480 |
| Gross Profit | £14,383 | £40,140 | £6,170 | -£13,583 |
| % Margin | 77% | 94.8% | 72.6% | -61.3% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £1,129 | £1,559 | £1,218 |
| SG&A Expenses | £0 | £1,129 | £1,559 | £1,218 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £2,324 | £0 |
| Operating Expenses | £0 | £1,129 | £3,883 | £1,218 |
| Operating Income | -£21 | £39,553 | £6,586 | -£17,281 |
| % Margin | -0.1% | 93.4% | 77.5% | -78% |
| Other Income/Exp. Net | -£1,121 | -£542 | £349 | -£5,041 |
| Pre-Tax Income | -£1,142 | £39,011 | £6,935 | -£22,322 |
| Tax Expense | £28 | £135 | £122 | £151 |
| Net Income | -£1,170 | £38,876 | £6,813 | -£22,473 |
| % Margin | -6.3% | 91.8% | 80.2% | -101.5% |
| EPS | -0.033 | 1.02 | 0.17 | -0.55 |
| % Growth | -103.2% | 500% | 130.9% | – |
| EPS Diluted | -0.033 | 1.02 | 0.17 | -0.55 |
| Weighted Avg Shares Out | 35,541 | 38,184 | 40,583 | 41,072 |
| Weighted Avg Shares Out Dil | 35,541 | 38,184 | 40,583 | 41,072 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £218 | £23 | £0 |
| Interest Expense | £0 | £2,198 | £1,242 | £663 |
| Depreciation & Amortization | £0 | £0 | -£6,586 | £17,281 |
| EBITDA | -£21 | £39,553 | £0 | £0 |
| % Margin | -0.1% | 93.4% | 0% | 0% |